{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,18]],"date-time":"2026-06-18T05:28:39Z","timestamp":1781760519745,"version":"3.54.5"},"reference-count":20,"publisher":"Oxford University Press (OUP)","issue":"5","license":[{"start":{"date-parts":[[2024,8,24]],"date-time":"2024-08-24T00:00:00Z","timestamp":1724457600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"funder":[{"name":"Novartis Farma"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,10,8]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Background<\/jats:title>\n                  <jats:p>Hidradenitis suppurativa (HS) is a persistent skin disorder that is characterized by painful lesions or pus-filled lumps, mostly occurring in areas where the skin flexes. It is a disfiguring condition that significantly reduces the quality of life of those affected. Developing new, effective treatments for HS is crucial, but it is important that it be recognized and diagnosed early, especially in primary care settings.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Objectives<\/jats:title>\n                  <jats:p>To assess the epidemiology and clinical correlates of HS in a primary care setting. The study utilized the Italian Health Search Database (HSD). A case-control design was adopted to investigate the clinical correlates of HS. Cases were classified as either \u201cdefinite\u201d or \u201cprobable\u201d using an operational algorithm. Up to 10 controls were matched to each case based on factors such as calendar period, age, sex, and duration of follow-up.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>Cumulative prevalence of HS increased from 0.06% in 2002 to 0.46% in 2021. When only \u201cdefinite\u201d cases were considered, the prevalence was almost 10 times lower (0%\u20130.02%). Several clinical correlates were found to be positively associated with HS, including obesity, dyslipidemia, hypertension, autoimmune\/inflammatory diseases, and depression.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusions<\/jats:title>\n                  <jats:p>This study found that correct diagnoses of HS were made, as demonstrated by the expected relationship with clinical correlates. These associations were consistent when probable cases were included in the analysis. This evidence could serve as a foundation for proposing a decision support system for general practitioners to help identify HS in individuals with certain coexisting conditions.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/fampra\/cmae037","type":"journal-article","created":{"date-parts":[[2024,8,25]],"date-time":"2024-08-25T00:55:19Z","timestamp":1724547319000},"page":"711-718","source":"Crossref","is-referenced-by-count":4,"title":["Epidemiology and clinical correlates of hidradenitis suppurativa in primary care in Italy"],"prefix":"10.1093","volume":"41","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4342-9128","authenticated-orcid":false,"given":"Francesco","family":"Lapi","sequence":"first","affiliation":[{"name":"Health Search, Italian College of General Practitioners and Primary Care , 50142, Florence ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ettore","family":"Marconi","sequence":"additional","affiliation":[{"name":"Health Search, Italian College of General Practitioners and Primary Care , 50142, Florence ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucia","family":"Casoli","sequence":"additional","affiliation":[{"name":"Novartis Farma S.p.A. , 20154, Milan ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Tedeschi","sequence":"additional","affiliation":[{"name":"Novartis Farma S.p.A. , 20154, Milan ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbara","family":"Giomi","sequence":"additional","affiliation":[{"name":"Specialist in Dermatology and Venereology , 50144, Florence ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudio","family":"Cricelli","sequence":"additional","affiliation":[{"name":"Italian College of General Practitioners and Primary Care , 50142, Florence ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2024,8,24]]},"reference":[{"key":"2024100903334658400_CIT0001","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1016\/j.jaad.2019.08.090","article-title":"Hidradenitis suppurativa: epidemiology, clinical presentation, and pathogenesis","volume":"82","author":"Goldburg","year":"2020","journal-title":"J Am Acad Dermatol"},{"key":"2024100903334658400_CIT0002","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1001\/jamadermatol.2021.1677","article-title":"Prevalence of Hidradenitis suppurativa: a systematic review and meta-regression analysis","volume":"157","author":"Jfri","year":"2021","journal-title":"JAMA Dermatol"},{"key":"2024100903334658400_CIT0003","doi-asserted-by":"crossref","first-page":"1597","DOI":"10.1111\/jdv.18163","article-title":"Unmet clinical needs and burden of disease in hidradenitis suppurativa: real-world experience from EU5 and US","volume":"36","author":"Ingram","year":"2022","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"2024100903334658400_CIT0004","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1111\/bjd.19435","article-title":"The epidemiology of hidradenitis suppurativa","volume":"183","author":"Ingram","year":"2020","journal-title":"Br J Dermatol"},{"key":"2024100903334658400_CIT0005","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1111\/bjd.16101","article-title":"Population-based Clinical Practice Research Datalink study using algorithm modelling to identify the true burden of hidradenitis suppurativa","volume":"178","author":"Ingram","year":"2018","journal-title":"Br J Dermatol"},{"key":"2024100903334658400_CIT0006","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1111\/j.1600-0625.2008.00712_1.x","article-title":"What causes hidradenitis suppurativa","volume":"17","author":"Kurzen","year":"2008","journal-title":"Exp Dermatol"},{"key":"2024100903334658400_CIT0007","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1111\/srt.12759","article-title":"Hidradenitis suppurativa: Current understanding, diagnostic and surgical challenges, and developments in ultrasound application","volume":"26","author":"Elkin","year":"2020","journal-title":"Skin Res Technol"},{"key":"2024100903334658400_CIT0008","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1093\/fampra\/cmaa140","article-title":"Education of general practitioners in the use of point-of-care ultrasonography: a systematic review","volume":"38","author":"Andersen","year":"2021","journal-title":"Fam Pract"},{"key":"2024100903334658400_CIT0009","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1080\/14656566.2022.2070429","article-title":"Advances in biologic and small molecule therapies for hidradenitis suppurativa","volume":"23","author":"Chen","year":"2022","journal-title":"Expert Opin Pharmacother"},{"key":"2024100903334658400_CIT0010","doi-asserted-by":"crossref","first-page":"1522","DOI":"10.1111\/exd.14619","article-title":"IL-17A is a pertinent therapeutic target for moderate to severe hidradenitis suppurativa: combined results from a pre-clinical and phase II proof-of-concept study","volume":"31","author":"Kimball","year":"2022","journal-title":"Exp Dermatol"},{"key":"2024100903334658400_CIT0011","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1016\/S0140-6736(23)00022-3","article-title":"Secukinumab in moderate-to-severe hidradenitis suppurativa (SUNSHINE and SUNRISE): week 16 and week 52 results of two identical, multicentre, randomised, placebo-controlled, double-blind phase 3 trials","volume":"401","author":"Kimball","year":"2023","journal-title":"Lancet"},{"key":"2024100903334658400_CIT0012","first-page":"339","article-title":"Risk factors associated with hidradenitis suppurativa comorbid with inflammatory bowel disease and clinical phenotypes: a pilot case-control study","volume":"62","author":"Jfri","year":"2022","journal-title":"Int J Dermatol"},{"key":"2024100903334658400_CIT0013","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1038\/s41572-020-0149-1","article-title":"Hidradenitis suppurativa","volume":"6","author":"Sabat","year":"2020","journal-title":"Nat Rev Dis Prim"},{"key":"2024100903334658400_CIT0014","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1080\/09546634.2019.1670779","article-title":"Isotretinoin in the treatment of hidradenitis suppurativa: a retrospective study","volume":"32","author":"Patel","year":"2021","journal-title":"J Dermatolog Treat"},{"key":"2024100903334658400_CIT0015","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1093\/pubmed\/21.3.299","article-title":"Clinical information for research; the use of general practice databases","volume":"21","author":"Lawrenson","year":"1999","journal-title":"J Public Health Med"},{"key":"2024100903334658400_CIT0016","article-title":"VIII Report Health Search","author":"Bianchini"},{"key":"2024100903334658400_CIT0017","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.bone.2011.09.048","article-title":"Assessing 5-year incidence rates and determinants of osteoporotic fractures in primary care","volume":"50","author":"Lapi","year":"2012","journal-title":"Bone"},{"key":"2024100903334658400_CIT0018","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1016\/j.jval.2015.05.004","article-title":"Development and validation of a score for adjusting health care costs in general practice","volume":"18","author":"Lapi","year":"2015","journal-title":"Value Heal"},{"key":"2024100903334658400_CIT0019","first-page":"593","article-title":"Incidence of psoriasis and association with comorbidities in Italy: a 5-year observational study from a national primary care database","volume":"20","author":"Vena","year":"2010","journal-title":"Eur J Dermatol"},{"key":"2024100903334658400_CIT0020","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.jaad.2019.02.068","article-title":"North American clinical management guidelines for hidradenitis suppurativa: a publication from the united states and Canadian hidradenitis suppurativa foundations: part II: topical, intralesional, and systemic medical management","volume":"81","author":"Alikhan","year":"2019","journal-title":"J Am Acad Dermatol"}],"container-title":["Family Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/fampra\/article-pdf\/41\/5\/711\/59644772\/cmae037.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/fampra\/article-pdf\/41\/5\/711\/59644772\/cmae037.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,9]],"date-time":"2024-10-09T03:34:05Z","timestamp":1728444845000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/fampra\/article\/41\/5\/711\/7740772"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8,24]]},"references-count":20,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2024,8,24]]},"published-print":{"date-parts":[[2024,10,8]]}},"URL":"https:\/\/doi.org\/10.1093\/fampra\/cmae037","relation":{},"ISSN":["1460-2229"],"issn-type":[{"value":"1460-2229","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2024,10]]},"published":{"date-parts":[[2024,8,24]]}}}